Metformin: update on mechanisms of action and repurposing potential

M Foretz, B Guigas, B Viollet - Nature Reviews Endocrinology, 2023 - nature.com
Currently, metformin is the first-line medication to treat type 2 diabetes mellitus (T2DM) in
most guidelines and is used daily by> 200 million patients. Surprisingly, the mechanisms …

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

M Foretz, B Guigas, B Viollet - Nature Reviews Endocrinology, 2019 - nature.com
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the
mechanisms underlying the plasma glucose level-lowering effects of metformin (1, 1 …

Current status and applications of genome-scale metabolic models

C Gu, GB Kim, WJ Kim, HU Kim, SY Lee - Genome biology, 2019 - Springer
Genome-scale metabolic models (GEMs) computationally describe gene-protein-reaction
associations for entire metabolic genes in an organism, and can be simulated to predict …

[HTML][HTML] Recognizing the benefits of pre-/probiotics in metabolic syndrome and type 2 diabetes mellitus considering the influence of akkermansia muciniphila as a key …

RA Corb Aron, A Abid, CM Vesa, AC Nechifor, T Behl… - Microorganisms, 2021 - mdpi.com
Metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are diseases that can be
influenced by the structure of gut microbiota, whose improvement is often neglected in …

Role of gut microbiota on onset and progression of microvascular complications of type 2 diabetes (T2DM)

DM Tanase, EM Gosav, E Neculae, CF Costea… - Nutrients, 2020 - mdpi.com
Type 2 diabetes mellitus (T2DM) remains one of the most problematic and economic
consumer disorders worldwide, with growing prevalence and incidence. Over the last years …

The critical role of Faecalibacterium prausnitzii in human health: An overview

HE Leylabadlo, R Ghotaslou, MM Feizabadi… - Microbial …, 2020 - Elsevier
Faecalibacterium prausnitzii (F. prausnitzii) is one of the most abundant bacterial species in
the colon of healthy human adults and representing more than 5% of the total bacterial …

The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus

CB Lee, SU Chae, SJ Jo, UM Jerng… - International journal of …, 2021 - mdpi.com
Metformin is the first-line pharmacotherapy for treating type 2 diabetes mellitus (T2DM);
however, its mechanism of modulating glucose metabolism is elusive. Recent advances …

Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease

D Rosario, G Bidkhori, S Lee, J Bedarf, F Hildebrand… - Cell reports, 2021 - cell.com
Parkinson's disease (PD) is the most common progressive neurological disorder
compromising motor functions. However, nonmotor symptoms, such as gastrointestinal (GI) …

Modulating the microbiota as a therapeutic intervention for type 2 diabetes

MN Huda, M Kim, BJ Bennett - Frontiers in endocrinology, 2021 - frontiersin.org
Mounting evidence suggested that the gut microbiota has a significant role in the
metabolism and disease status of the host. In particular, Type 2 Diabetes (T2D), which has a …

Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial

NT Mueller, MK Differding, M Zhang… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE To determine the longer-term effects of metformin treatment and behavioral
weight loss on gut microbiota and short-chain fatty acids (SCFAs). RESEARCH DESIGN …